Encompass Health Raises 2026 Revenue Outlook Following Strong Q3 Growth
Encompass Health (EHC) has raised its full-year 2026 revenue guidance to a range of $6.45 billion to $6.5 billion. This upward revision follows robust third-quarter performance, characterized by an 8.9% increase in revenue and a significant 15.5% rise in adjusted EBITDA. The company is currently focused on expanding its capacity, while managing pre-opening costs estimated between $20 million and $24 million. Management expressed confidence in the growth trajectory, noting that adjusted earnings per share (EPS) saw a substantial increase of 23.6% during the quarter.
Tickers: $EHC
Topics: EBITDA EPS Guidance Upgrade Revenue Growth
Read the full article at Seeking Alpha
Part of the story Vanda Pharmaceuticals Projects 2026 Revenues Exceeding $240 Million Following Q3 Growth (3 articles)